- Home
- AVNS
AVNS
Avanos Medical Inc.
as 04-18-2025 1:31pm EST
Avanos Medical Inc is a United States-based company that develops and sells medical devices and related services globally. Its operating and reportable segment provides medical device products to healthcare providers and patients. The company has now changed two franchises: has combined Chronic Care and Pain Management franchises into a single commercial organization focused on the Digestive Health and Pain Management and Recovery product categories that generate its revenue from its Chronic Care franchise and in North America.
| Founded: | 2014 | Country: | United States |
| Employees: | N/A | City: | ALPHARETTA |
| Market Cap: | 641.7M | IPO Year: | N/A |
| Target Price: | N/A | AVG Volume (30 days): | 501.5K |
| Analyst Decision: | Hold | Number of Analysts: | 1 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -8.53 | EPS Growth: | N/A |
| 52 Week Low/High: | $11.90 - $25.36 | Next Earning Date: | 05-01-2025 |
| Revenue: | $687,800,000 | Revenue Growth: | 2.15% |
| Revenue Growth (this year): | -0.12% | Revenue Growth (next year): | 3.36% |
Stock Insider Trading Activity of Avanos Medical Inc. (AVNS)
| Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| Holbrook Kerr | AVNS | SVP, Chief Commercial Officer | Mar 6 '25 | Sell | $15.25 | 7,000 | $106,778.00 | 82,047 |
Latest Avanos Medical Inc. News
AVNS Breaking Stock News: Dive into AVNS Ticker-Specific Updates for Smart Investing
Argus Research
4 days ago
AVNS: Lowering target price to $13.00
Argus Research
11 days ago
AVNS: Lowering target price to $14.00
Zacks
16 days ago
AVNS Stock Gains Following Direct Sales Deal for MIC-KEY in the UK
MT Newswires
17 days ago
Avanos Medical to Take Direct Control of MIC-KEY Sales, Distribution in UK
PR Newswire
17 days ago
Avanos Expands Direct Operations for MIC-KEY* Enteral Feeding Products in the UK starting July 2025
Argus Research
18 days ago
AVNS: Rating increased to a BUY
Zacks
22 days ago
Avanos Medical (AVNS) Down 5.8% Since Last Earnings Report: Can It Rebound?
Argus Research
25 days ago
AVNS: What does Argus have to say about AVNS?
Compare AVNS vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "AVNS Avanos Medical Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.